Abbott To Take mAbxience Biosimilars To Emerging Markets From 2025

Builds On Initial 2018 Agreement While Aligning With Fresenius Kabi’s 2026 Vision

 
• By Dean Rudge
  
Sarunyu_foto/Shutterstock.com
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products